RXFP1 and leukemia: Relaxin signaling, primarily through RXFP1, has been implicated in disease contexts such as leukemia and preeclampsia, with elevated receptor expression linked to poorer survival in leukemia patients and decreased placental expression associated with later development of preeclampsia [32,71,73].